Want to see ICCC full AI Analyst Report?
Total Valuation
Immucell has a market cap or net worth of $90.64M. The enterprise value is $95.94.
Market Cap$90.64M
Enterprise Value$95.94
Share Statistics
Immucell has 9,082,197 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding9,082,197
Owned by Insiders4.07%
Owned by Institutions2.26%
Financial Efficiency
Immucell’s return on equity (ROE) is -0.04 and return on invested capital (ROIC) is 4.10%.
Return on Equity (ROE)-0.04
Return on Assets (ROA)-0.02
Return on Invested Capital (ROIC)4.10%
Return on Capital Employed (ROCE)0.04
Revenue Per Employee378.69K
Profits Per Employee-14.25K
Employee Count73
Asset Turnover0.65
Inventory Turnover1.75
Valuation Ratios
The current PE Ratio of Immucell is 117.6. Immucell’s PEG ratio is 0.95.
PE Ratio117.6
PS Ratio2.01
PB Ratio2.05
Price to Fair Value2.05
Price to FCF45.32
Price to Operating Cash Flow15.31
PEG Ratio0.95
Income Statement
In the last 12 months, Immucell had revenue of 27.64M and earned -1.04M in profits. Earnings per share was -0.12.
Revenue27.64M
Gross Profit11.45M
Operating Income1.65M
Pretax Income-1.03M
Net Income-1.04M
EBITDA2.14M
Earnings Per Share (EPS)-0.12
Cash Flow
In the last 12 months, operating cash flow was 5.89M and capital expenditures -1.68M, giving a free cash flow of 4.21M billion.
Operating Cash Flow5.89M
Free Cash Flow4.21M
Free Cash Flow per Share0.46
Dividends & Yields
Immucell pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.03
52-Week Price Change59.20%
50-Day Moving Average10.48
200-Day Moving Average8.24
Relative Strength Index (RSI)47.70
Average Volume (3m)25.70K
Important Dates
Immucell upcoming earnings date is Nov 12, 2026, After Close (Confirmed).
Last Earnings DateAug 13, 2026
Next Earnings DateNov 12, 2026
Ex-Dividend Date―
Financial Position
Immucell as a current ratio of 4.26, with Debt / Equity ratio of 39.67%
Current Ratio4.26
Quick Ratio1.93
Debt to Market Cap0.16
Net Debt to EBITDA4.39
Interest Coverage Ratio3.76
Taxes
In the past 12 months, Immucell has paid 11.57K in taxes.
Income Tax11.57K
Effective Tax Rate-0.01
Enterprise Valuation
Immucell EV to EBITDA ratio is 30.32, with an EV/FCF ratio of 52.98.
EV to Sales2.35
EV to EBITDA30.32
EV to Free Cash Flow52.98
EV to Operating Cash Flow26.22
Balance Sheet
Immucell has $8.86M in cash and marketable securities with $12.45M in debt, giving a net cash position of -$3.59M billion.
Cash & Marketable Securities$8.86M
Total Debt$12.45M
Net Cash-$3.59M
Net Cash Per Share-$0.39
Tangible Book Value Per Share$2.99
Margins
Gross margin is 40.32%, with operating margin of 5.97%, and net profit margin of -3.76%.
Gross Margin40.32%
Operating Margin5.97%
Pretax Margin-3.72%
Net Profit Margin-3.76%
EBITDA Margin7.74%
EBIT Margin-2.13%
Analyst Forecast
The average price target for Immucell is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast8.49%
EPS Growth Forecast-54.03%